Symbol="ETNB"
AssetType="Common Stock"
Name="89bio Inc"
Description="89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardiometabolic diseases. The company is headquartered in San Francisco, California."
CIK="1785173"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="535 MISSION STREET, 14TH FLOOR, SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1246944000"
EBITDA="-123001000"
PERatio="None"
PEGRatio="None"
BookValue="5.86"
DividendPerShare="0"
DividendYield="0"
EPS="-1.5"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.24"
ReturnOnEquityTTM="-0.454"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.5"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="37"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="3.111"
EVToRevenue="-"
EVToEBITDA="-2.924"
Beta="0.724"
num_52WeekHigh="22.93"
num_52WeekLow="4.15"
num_50DayMovingAverage="17.42"
num_200DayMovingAverage="14.53"
SharesOutstanding="75481000"
DividendDate="None"
ExDividendDate="None"
symbol="ETNB"
open="16.55"
high="16.73"
low="16.25"
price="16.52"
volume="493177.00"
latest_trading_day="2023-08-25"
previous_close="16.55"
change="-0.03"
change_percent="-0.1813%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="22"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="78"
Volume_recent_avg="1262572"
Change_recent_avg="0.01"
Delta_recent_avg="0.98"
Variance_recent_avg="0.49"
Change_ratio_recent_avg="0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="78"
Aroon_momentum_negative="22"
image_negative_thumbnail_id_1="520"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0085.jpeg"
image_negative_thumbnail_id_2="510"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0095.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="597"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_positive_thumbnail_id_1="599"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0109.jpeg"
image_positive_thumbnail_id_2="1013"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
